HIV Citation List: September 28 - October 11, 2012

PubMed citations

1. Ionic Derivatives of Betulinic acid as Novel HIV-1 Protease Inhibitors. Zhao, H., S.S. Holmes, G.A. Baker, S. Challa, H.S. Bose, and Z. Song. Journal of Enzyme Inhibition and Medicinal Chemistry, 2012. 27(5): p. 715-721. PMID[21985312].

[PubMed].HIV_0928-101112.

2. Phosphoramidate Derivatives of Acyclovir: Synthesis and Antiviral Activity in HIV-1 and HSV-1 Models in Vitro. Zakirova, N.F., A.V. Shipitsyn, M.V. Jasko, M.M. Prokofjeva, V.L. Andronova, G.A. Galegov, V.S. Prassolov, and S.N. Kochetkov. Bioorganic & Medicinal Chemistry, 2012. 20(19): p. 5802-5809. PMID[22954898].

[PubMed].HIV_0928-101112.

3. Nitrogen-containing Polyhydroxylated Aromatics as HIV-1 Integrase Inhibitors: Synthesis, Structure-Activity Relationship Analysis, and Biological Activity. Yu, S., L. Zhang, S. Yan, P. Wang, T. Sanchez, F. Christ, Z. Debyser, N. Neamati, and G. Zhao. Journal of Enzyme Inhibition and Medicinal Chemistry, 2012. 27(5): p. 628-640. PMID[22233539].

[PubMed].HIV_0928-101112.

4. CXCR4 Chemokine Receptor Antagonists: Nickel(II) Complexes of Configurationally Restricted Macrocycles. Smith, R., D. Huskens, D. Daelemans, R.E. Mewis, C.D. Garcia, A.N. Cain, T.N. Freeman, C. Pannecouque, E.D. Clercq, D. Schols, T.J. Hubin, and S.J. Archibald. Dalton Transactions, 2012. 41(37): p. 11369-11377. PMID[22892890].

[PubMed]. HIV_0928-101112.

5. Caveolin-1 Suppresses Human Immunodeficiency Virus-1 Replication by Inhibiting Acetylation of Nf-Kappa-b. Simmons, G.E., Jr., H.E. Taylor, and J.E. Hildreth. Virology, 2012. 432(1): p. 110-119. PMID[22748181].

[PubMed].HIV_0928-101112.

6. Transmembrane Protein Aptamers that Inhibit CCR5 Expression and HIV Coreceptor Function. Scheideman, E.H., S.A. Marlatt, Y. Xie, Y. Hu, R.E. Sutton, and D. Dimaio. Journal of Virology, 2012. 86(19): p. 10281-10292. PMID[22811524].

[PubMed].HIV_0928-101112.

7. A Suite of Modular Fluorescence Assays Interrogate the Human Immunodeficiency Virus Glycoprotein-41 Coiled Coil and Assist in Determining Binding Mechanism of Low Molecular Weight Fusion Inhibitors. Gochin, M. Assay and Drug Development Technologies, 2012. 10(5): p. 407-416. PMID[22897493].

[PubMed].HIV_0928-101112.

8. In Vitro anti-HIV-1 Activity of Salicylidene acylhydrazide Compounds. Forthal, D.N., T.B. Phan, A.V. Slepenkin, G. Landucci, H. Chu, M. Elofsson, and E. Peterson. International Journal of Antimicrobial Agents, 2012. 40(4): p. 354-360. PMID[22819150].

[PubMed].HIV_0928-101112.

9. A Quantitative Measurement of Antiviral Activity of Anti-Human Immunodeficiency Virus Type 1 Drugs against Simian Immunodeficiency Virus Infection: Dose-response Curve Slope Strongly Influences Class-specific Inhibitory Potential. Deng, K., M.C. Zink, J.E. Clements, and R.F. Siliciano. Journal of Virology, 2012. 86(20): p. 11368-11372. PMID[22875968].

[PubMed].HIV_0928-101112.

10. Correlating Conformational Shift Induction with Altered Inhibitor Potency in a Multidrug Resistant HIV-1 Protease Variant. de Vera, I.M., M.E. Blackburn, and G.E. Fanucci. Biochemistry, 2012. 51(40): p. 7813-7815. PMID[23009326].

[PubMed].HIV_0928-101112.

11. The M-T Hook Structure Is Critical for Design of HIV-1 Fusion Inhibitors. Chong, H., X. Yao, J. Sun, Z. Qiu, M. Zhang, S. Waltersperger, M. Wang, S. Cui, and Y. He. The Journal of Biological Chemistry, 2012. 287(41): p. 34558-34568. PMID[22892387].

[PubMed].HIV_0928-101112.

ISI Web of Knowledge Citations

12. Topical Gel Formulation of Broadly Neutralizing anti-HIV-1 Monoclonal Antibody Vrc01 Confers Protection against HIV-1 Vaginal Challenge in a Humanized Mouse Model. Veselinovic, M., C.P. Neff, L.R. Mulder, and R. Akkina. Virology, 2012. 432(2): p. 505-510. ISI[000308121600029].

[WOS].HIV_0928-101112.

13. In Search for a New anti-HIV-1 Drug through Inhibition of Ca-Cypa Interaction. Verathamjamras, C., Y.S. Tian, T. Yasunaga, T. Takagi, N. Kawashita, and M. Kameoka. International Journal of Infectious Diseases, 2012. 16: p. E194-E194. ISI[000308353101087].

[WOS]. HIV_0928-101112.

14. Selected Drugs with Reported Secondary Cell-Differentiating Capacity Prime Latent HIV-1 Infection for Reactivation. Shishido, T., F. Wolschendorf, A. Duverger, F. Wagner, J. Kappes, J. Jones, and O. Kutsch. Journal of Virology, 2012. 86(17): p. 9055-9069. ISI[000307627800012].

[WOS]. HIV_0928-101112.

15. Synthesis and Conformation of Novel 3'-branched Threosyl-5'-deoxyphosphonic acid Nucleoside Analogues. Shen, G.H., L. Kang, E. Kim, W. Lee, and J.H. Hong. Bulletin of the Korean Chemical Society, 2012. 33(8): p. 2574-2580. ISI[000308115300020].

[WOS]. HIV_0928-101112.

16. Identification and Optimization of a Novel Class of HIV Fusion Inhibitors via High-Throughput Synthesis & Screening of Peptide Arrays. Schepens, W., W. Schaaper, P. Timmerman, C. Buyck, J. Slootstra, O. Goethals, B. Stoops, N. Kriek, K. Amssoms, J. Benschop, J. Wu, G. Dams, K. Van Emelen, J.W. Thuring, and B. Malcolm. Journal of Peptide Science, 2012. 18: p. S142-S142. ISI[000308091500341].

[WOS].HIV_0928-101112.

17. Diverse Combinatorial Design, Synthesis and in Vitro Evaluation of New Hept Analogues as Potential Non-nucleoside HIV-1 Reverse Transcription Inhibitors.

Puig-de-la-Bellacasa, R., L. Gimenez, S. Pettersson, R. Pascual, E. Gonzalo, J.A. Este, B. Clotet, J.I. Borrell, and J. Teixido. European Journal of Medicinal Chemistry, 2012. 54: p. 159-174. ISI[000307920600017].

[WOS]. HIV_0928-101112.

18. 3-Phenylcoumarins as Inhibitors of HIV-1 Replication. Olmedo, D., R. Sancho, L.M. Bedoya, J.L. Lopez-Perez, E. del Olmo, E. Munoz, J. Alcami, M.P. Gupta, and A.S. Feliciano. Molecules, 2012. 17(8): p. 9245-9257. ISI[000308211100039].

[WOS].HIV_0928-101112.

19. Use of ATP Analogs to Inhibit HIV-1 Transcription. Narayanan, A., G. Sampey, R. Van Duyne, I. Guendel, K. Kehn-Hall, J. Roman, R. Currer, H. Galons, N. Oumata, B. Joseph, L. Meijer, M. Caputi, S. Nekhai, and F. Kashanchi. Virology, 2012. 432(1): p. 219-231. ISI[000307027100024].

[WOS].HIV_0928-101112.

20. (Naphthalen-1-tloxy)-acetic acid benzylidene/(1-phenyl-ethylidene)-hydrazide Derivatives: Synthesis, Antimicrobial Evaluation, and QSAR Studies. Narang, R., B. Narasimhan, and S. Sharma. Medicinal Chemistry Research, 2012. 21(9): p. 2526-2547. ISI[000307268100045].

[WOS].HIV_0928-101112.

21. Inhibition of XMRV and HIV-1 Proteases by Pepstatin A and Acetyl-pepstatin. Matuz, K., J. Motyan, M. Li, A. Wlodawer, and J. Tozser. Federation of European Biochemical Societies Journal, 2012. 279(17): p. 3276-3286. ISI[000307883100024].

[WOS].HIV_0928-101112.

22. De novo Design of Artificial Peptides That Specifically Interact with HIV-1 gp41 to Inhibit Viral-Cell Membrane Fusion and Infection. Liu, K., L. Cai, W. Shi, C. Wang, and K. Wang. Journal of Peptide Science, 2012. 18: p. S22-S23. ISI[000308091500011].

[WOS].HIV_0928-101112.

23. APOBEC3G Inhibits MicroRNA-mediated Repression of Translation by Interfering with the Interaction between Argonaute-2 and MOV10. Liu, C., X. Zhang, F. Huang, B. Yang, J. Li, B.F. Liu, H.H. Luo, P. Zhang, and H. Zhang. Journal of Biological Chemistry, 2012. 287(35): p. 29373-29383. ISI[000308286900016].

[WOS].HIV_0928-101112.

24. First Total Syntheses of Oresbiusins A and B, Their Antipodes, and Racemates: Configuration Revision and anti-HIV Activity. Hwu, J.R., T.G. Varadaraju, I.S. Abd-Elazem, and R.C.C. Huang. European Journal of Organic Chemistry, 2012. (25): p. 4684-4688. ISI[000307937800004]. [WOS]. HIV_0928-101112.

25. Use of Substituted Oxamide Structure in Designing Pseudo-symmetric HIV Protease Inhibitors to Employ Multiple Bridging Water Molecules. Hidaka, K., Y. Toda, M. Adachi, R. Kuroki, and Y. Kiso. Journal of Peptide Science, 2012. 18: p. S129-S130. ISI[000308091500306].

[WOS].HIV_0928-101112.

26. Identification of Novel T Cell Factor 4 (TCF-4) Binding Sites on the HIV Long Terminal Repeat Which Associate with TCF-4, Beta-catenin, and SMAR1 to Repress HIV Transcription. Henderson, L.J., S.D. Narasipura, V. Adarichev, F. Kashanchi, and L. Al-Harthi. Journal of Virology, 2012. 86(17): p. 9495-9503. ISI[000307627800051].

[WOS].HIV_0928-101112.

27. 8-O-4'-Neolignans from Flower Buds of Magnolia fargesii and Their Biological Activities. Gao, X.M., Y.Q. Shen, L.Y. Yang, L.D. Shu, G.P. Li, and Q.F. Hu. Journal of the Brazilian Chemical Society, 2012. 23(7): p. 1274. ISI[000307437800011].

[WOS].HIV_0928-101112.

28. A Conformationally Frozen Peptoid Boosts CXCR4 Affinity and anti-HIV Activity. Demmer, O., A.O. Frank, F. Hagn, M. Schottelius, L. Marinelli, S. Cosconati, R. Brack-Werner, S. Kremb, H.J. Wester, and H. Kessler. Angewandte Chemie-International Edition, 2012. 51(32): p. 8110-8113. ISI[000307215600053].

[WOS].HIV_0928-101112.

29. A Synthetic Heparan Sulfate-mimetic Peptide Conjugated to a Mini CD4 Displays Very High anti-HIV Activity. Connell, B.J., F. Baleux, Y.M. Coic, P. Clayette, D. Bonnaffe, and H. Lortat-Jacob. Journal of Peptide Science, 2012. 18: p. S45-S46. ISI[000308091500075].

[WOS].HIV_0928-101112.

30. Cleidbrevoids A-C, New Clerodane Diterpenoids from Cleidion brevipetiolatum. Cheng, Y.Y., S.F. Li, Y. Zhang, G.H. Tang, Y.T. Di, X.J. Hao, S.L. Li, and H.P. He. Fitoterapia, 2012. 83(6): p. 1100-1104. ISI[000308116600020].

[WOS].HIV_0928-101112.

31. An Efficient Synthesis of a Hydroxyethylamine (HEA) Isostere and Its a-Aminophosphonate and Phosphoramidate Derivatives as Potential anti-HIV Agents. Bhattacharya, A.K., K.C. Rana, C. Pannecouque, and E. De Clercq. Chemmedchem, 2012. 7(9): p. 1601-1611. ISI[000308042000010].

[WOS].HIV_0928-101112.

Patent Citations

32. Preparation of Cyclic Peptides Containing Amidine Bond as Novel Chemokine Receptor Antagonist. Fujii, N., H. Ohno, S. Oishi, E. Inokuchi, T. Kubo, M. Matsuoka, and K. Shimura. Patent. 2012. 2012-JP55099 2012118124: 60pp.

[Patent]. HIV_0928-101112.

33. Preparation of 1,2,3-Thiadiazole Derivatives for Treatment of HIV Infection. Liu, X., X. Jiang, and P. Zhan. Patent. 2012. 2012-10146323 102659714: 10pp.

[Patent]. HIV_0928-101112.

34. Potent HIV-Inhibiting Chimeric Polypeptides Targeting CCR5 and gp41. Liwang, P. and B. Zhao. Patent. 2012. 2012-US24265 2012109314: 87pp.

[Patent]. HIV_0928-101112.

35. Preparation of 2'-Allene-substituted Nucleoside Derivs. As Antiviral Agents. Or, Y.S., J. Ma, G. Wang, I.J. Kim, J. Long, and Y.-L. Qiu. Patent. 2012. 2012-US29381 2012125900: 269pp.

[Patent]. HIV_0928-101112.